Masimo (MASI) Other Working Capital Changes (2009 - 2026)
Masimo's (MASI) quarterly Other Working Capital Changes came in at -$9.4 million in Q2 2026, down 394.74% year-on-year from $3.2 million in Q2 2025, and up 12.96% quarter-over-quarter from -$10.8 million in Q1 2026.
Masimo (MASI) Other Working Capital Changes (2009 - 2026) Analysis & Trends
Masimo's Other Working Capital Changes history runs 18 years deep, the most recent figure standing at -$9.4 million for Q2 2026.
- On a quarterly basis, Other Working Capital Changes fell 394.74% year-over-year to -$9.4 million in Q2 2026; TTM through Apr 2026 was -$19.0 million, a 3266.67% decrease from a year earlier, with the FY2026 full-year figure at -$11.5 million, down 47.44% from the prior year.
- Other Working Capital Changes rose to -$9.4 million in Q2 2026 per MASI's latest filing, from -$10.8 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $15.7 million in Q3 2024 and bottomed at -$16.9 million in Q1 2022.
- The 5-year median for Other Working Capital Changes is -$1.6 million (2022), against an average of -$481833.3.
- Across the five-year window, Other Working Capital Changes surged 2516.67% in 2024 and tumbled 394.74% in 2026, its largest moves.
- Year by year, Other Working Capital Changes stood at $8.4 million in 2022, then jumped by 78.57% to $15.0 million in 2023, then plunged by 178.67% to -$11.8 million in 2024, then surged by 77.97% to -$2.6 million in 2025, then slumped by 261.54% to -$9.4 million in 2026.
- Per Business Quant, the three latest MASI Other Working Capital Changes figures stand at -$9.4 million (Q2 2026), -$10.8 million (Q1 2026), and -$2.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -9.40 Mn |
| Apr 4, 2026 | -9.40 Mn |
| Apr 4, 2026 | -9.40 Mn |
| Jan 3, 2026 | -10.80 Mn |
| Jan 3, 2026 | -10.80 Mn |
| Jan 3, 2026 | -10.80 Mn |
| Sep 27, 2025 | -2.60 Mn |
| Sep 27, 2025 | -2.60 Mn |
| Sep 27, 2025 | -2.60 Mn |
| Jun 28, 2025 | 3.80 Mn |
| Jun 28, 2025 | 3.80 Mn |
| Jun 28, 2025 | 3.80 Mn |
| Mar 29, 2025 | -1.90 Mn |
| Mar 29, 2025 | -1.90 Mn |
| Mar 29, 2025 | -1.90 Mn |
| Dec 28, 2024 | -11.80 Mn |
| Dec 28, 2024 | -11.80 Mn |
| Dec 28, 2024 | -11.80 Mn |
| Sep 28, 2024 | 15.70 Mn |
| Sep 28, 2024 | 15.70 Mn |